Gain Therapeutics's total assets for Q4 2024 were $12.12M, a decrease of -15.61% from the previous quarter. GANX total liabilities were $4.78M for the fiscal quarter, a -12.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.